Taipei, Saturday, July 26, 2014 13:36 (GMT+8)
mostly cloudy
Taipei
33°C
Taiwan PCB makers ramping up capacity - related company info
Ingrid Lee, Taipei; Steve Shen, DIGITIMES [Monday 19 November 2012]
  • APEX Medical
  • Performance
    The company's stock price closed at NT$55.7 on the TSE on Thursday, July 24, 2014.
    The company has reported consolidated revenues of NT$204 million for June 2014, representing a 0.2% drop on month and 40.3% increase on year.
    For the first quarter of 2014, the company totaled NT$581 million in consolidated revenues, up 11.6% sequentially and up 18.3% on year.
    Brief

    Full name: APEX Medical

    Chinese name: 雃博股份有限公司

    Short name: Apex

    Stock code: 4106

    Tax ID: 23632773

    Market: TSE

    Established: 17 Mar 1990

    Paid in capital: NT$833.86 million

    Listed on TSE: 8 Nov 2004

    Listed on OTC: 22 Jan 2002

    Listed on ESB: 2 Jan 2002

    Public since: 19 Jul 1999

    Website: cht.apexmedical.com.tw

  • Latest stock
    Apex [4106] historical stock price (NT$)
    DateVolume (k)TransactionsValueOpenHighLowCloseChangeAskBid
    25-Jul 2,912 1,861 159,059,879 55.70 56.70 53.20 54.80-0.90-1.62% 54.80 54.60
    24-Jul 3,491 2,088 196,476,389 55.90 57.80 55.30 55.70+0.00+0.00% 55.80 55.70
    22-Jul 2,475 1,440 140,486,962 58.50 58.60 55.30 55.60-1.10-1.94% 55.70 55.60
    21-Jul 1,994 1,255 114,065,120 58.00 58.40 56.60 56.70-1.30-2.24% 56.90 56.70
    18-Jul 5,186   55.00 58.80 54.60 58.00+2.00+3.57%  
    17-Jul 2,115 1,438 115,697,400 53.70 56.00 53.50 56.00+2.30+4.28% 56.00 55.90
    • Source: TSE, compiled by Digitimes
    Latest sales

    Apex: Consolidated revenues, Jun 2013 - Jun 2014 (NT$m)

    Month

    Sales

    M/M

    Y/Y

    YTD

    Y/Y

    Jun-14

    204

    (0.2%)

    40.3%

    1,177

    19%

    May-14

    205

    6.8%

    8.9%

    964

    14.4%

    Apr-14

    192

    (12.8%)

    16.9%

    760

    15.9%

    Mar-14

    220

    35.5%

    13.1%

    568

    15.6%

    Feb-14

    162

    (12.7%)

    18.5%

    348

    17.2%

    Jan-14

    186

    7%

    16%

    186

    16%

    Dec-13

    174

    21.5%

    6.5%

    1,959

    5.9%

    Nov-13

    143

    (18.2%)

    (0.1%)

    1,786

    5.8%

    Oct-13

    175

    15.7%

    19.3%

    1,643

    6.4%

    Sep-13

    151

    (4.3%)

    (11.1%)

    1,468

    5%

    Aug-13

    158

    (7%)

    (1%)

    1,317

    7.3%

    Jul-13

    170

    16.7%

    8.3%

    1,159

    8.5%

    Jun-13

    146

    (22.5%)

    4.3%

    989

    8.6%

    *Figures are consolidated
    Source: TSE, compiled by Digitimes, July 2014

    Apex: Consolidated revenues, 1Q13 - 1Q14 (NT$m)

    Quarter

    Sales

    Q/Q

    Y/Y

    YTD

    Y/Y

    1Q-14

    581

    11.6%

    18.3%

    581

    18.3%

    4Q-13

    521

    5.4%

    0.4%

    2,017

    9.3%

    3Q-13

    494

    (3.1%)

    17.5%

    1,496

    12.8%

    2Q-13

    510

    3.9%

    8.6%

    1,002

    10.5%

    1Q-13

    491

    (5.3%)

    12.7%

    491

    12.7%

    *Figures are consolidated
    Source: TSE, compiled by Digitimes, July 2014

    Latest balance sheet and income statement

    Apex: Consolidated balance sheet, 1Q13 - 1Q14 (NT$k)

    Item

    1Q-2014

    4Q-2013

    3Q-2013

    2Q-2013

    1Q-2013

    Current assets

    1,301,613

    1,078,245

    1,029,489

    1,095,523

    1,033,265

    Intangible assets

    580,933

    577,954

    572,223

    564,063

    568,064

    Non-current assets

    1,350,242

    1,351,082

    1,334,102

    1,328,174

    1,335,182

    Assets

    2,651,855

    2,429,327

    2,363,591

    2,423,697

    2,368,447

    Current liabilities

    739,553

    599,379

    606,240

    619,159

    575,018

    Non-current liabilities

    0

    143

    5,702

    5,887

    6,082

    Liabilities

    739,553

    599,522

    611,942

    625,046

    581,100

    Stockholders' equity

    1,912,302

    1,829,805

    1,751,649

    1,798,651

    1,787,347

    *Figures are consolidated
    Source: TSE, compiled by Digitimes, July 2014

    Apex: Consolidated income statement, 1Q13 - 1Q14 (NT$k)

    Item

    1Q-2014

    4Q-2013

    3Q-2013

    2Q-2013

    1Q-2013

    NT$k

    % of sales

    NT$k

    % of sales

    NT$k

    % of sales

    NT$k

    % of sales

    NT$k

    % of sales

    Gross sales

     

     

    521,003

     

    494,330

     

    0

     

     

     

    Operating revenue

    581,195

    111.6%

    521,003

    100%

    494,330

    100%

    510,292

     

    491,346

     

    Gross profit (loss) from operations

    264,312

    50.7%

    231,525

    44.4%

    198,806

    40.2%

    228,538

     

    192,128

     

    Operating expenses

    195,434

    37.5%

    188,542

    36.2%

    175,425

    35.5%

    164,532

     

    140,133

     

    Operating income (loss)

    68,878

    13.2%

    42,983

    8.3%

    23,381

    4.7%

    64,006

     

    51,995

     

    Non-operating expenses and losses

    11,339

    2.2%

    9,361

    1.8%

    3,038

    0.6%

    4,702

     

    4,091

     

    Income from continuing operations before income tax

    80,217

    15.4%

    52,344

    10%

    26,419

    5.3%

    68,708

     

    56,086

     

    Net income (loss)

    60,610

    11.6%

    46,285

    8.9%

    15,086

    3.1%

    40,460

     

    44,398

     

    Diluted earnings per share (NT$)

    0.7

     

    0.5

     

    0.2

     

    0.4

     

    0.5

     

    *Figures are consolidated
    Source: TSE, compiled by Digitimes, July 2014

  • APEX Medical full profile

25-Jul-2014 markets closed

 LastChange

TAIEX (TSE)9439.29-88.25-0.93% 

TSE electronic370.69-6.21-1.65% 

GTSM (OTC)148.31-1.57-1.05% 

OTC electronic184.19-1.44-0.78% 

UHD TV market forecast, 2014-2017
DIGITIMES Marketing Services
2014 global smartphone market forecast